MMP-2 mediates mesenchymal stem cell tropism towards medulloblastoma tumors

Gene Therapy

Volumn 18, Issue 7, 2011, Pages 692-701

  Bhoopathi, P ^a   Chetty, C ^a   Gogineni, V R ^a   Gujrati, M ^a   Dinh, D H ^a   Rao, J S ^a   Lakka, S S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

CXCR4; human umbilical cord blood stem cells; medulloblastoma; MMP 2; SDF1; tropism

Indexed keywords

ADENOVIRUS VECTOR; CHEMOKINE RECEPTOR CXCR4; RECOMBINANT ENZYME; RECOMBINANT GELATINASE A; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL MIGRATION; CONTROLLED STUDY; FIBROBLAST; GENE DELIVERY SYSTEM; HUMAN; HUMAN CELL; HUMAN UMBILICAL CORD BLOOD DERIVED STEM CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MEDULLOBLASTOMA; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TROPISM; TUMOR CELL; UMBILICAL CORD BLOOD; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL12; CULTURE MEDIA, CONDITIONED; FETAL BLOOD; GENE TRANSFER TECHNIQUES; HUMANS; MATRIX METALLOPROTEINASE 2; MEDULLOBLASTOMA; MESENCHYMAL STEM CELLS; MICE; RECEPTORS, CXCR4; TISSUE CULTURE TECHNIQUES;

EID: 79960128975     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2011.14     Document Type: Article

References (36)

1. Benedetti S, Pirola B, Pollo B, Magrassi L, Bruzzone MG, Rigamonti D et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 2000; 6: 447-450. (Pubitemid 30208163)
2. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000; 97: 12846-12851.
3. Yip S, Aboody KS, Burns M, Imitola J, Boockvar JA, Allport J et al. Neural stem cell biology may be well suited for improving brain tumor therapies. Cancer J 2003; 9: 189-204.
4. Lee KH, Choi EY, Hyun MS, Kim JR. Involvement of MAPK pathway in hypoxia-induced up-regulation of urokinase plasminogen activator receptor in a human prostatic cancer cell line, PC3MLN4. Exp Mol Med 2004; 36: 57-64. (Pubitemid 38374725)
5. Gang EJ, Hong SH, Jeong JA, Hwang SH, Kim SW, Yang IH et al. In vitro mesengenic potential of human umbilical cord blood-derived mesenchymal stem cells. Biochem Biophys Res Commun 2004; 321: 102-108. (Pubitemid 39055611)
6. Yang SE, Ha CW, Jung M, Jin HJ, Lee M, Song H et al. Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy 2004; 6: 476-486. (Pubitemid 39433582)
7. Kim SM, Lim JY, Park SI, Jeong CH, Oh JH, Jeong M et al. Gene therapy using TRAILsecreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res 2008; 68: 9614-9623.
8. Kollar K, Cook MM, Atkinson K, Brooke G. Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction. Int J Cell Biol 2009; E-pub ahead of print 12 July 2009; doi:10.1155/2009/904682.
9. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003; 200: 448-464. (Pubitemid 36818245)
10. Chang C, Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 2001; 11: S37-S43.
11. Mannello F, Tonti GA, Bagnara GP, Papa S. Role and function of matrix metalloproteinases in the differentiation and biological characterization of mesenchymal stem cells. Stem Cells 2006; 24: 475-481. (Pubitemid 44464750)
12. Karagiannis ED, Popel AS. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model. J Theor Biol 2006; 238: 124-145. (Pubitemid 41737802)
13. Segarra M, Vilardell C, Matsumoto K, Esparza J, Lozano E, Serra-Pages C et al. Dual function of focal adhesion kinase in regulating integrin-induced MMP-2 and MMP-9 release by human T lymphoid cells. FASEB J 2005; 19: 1875-1877. (Pubitemid 41598780)
14. De Becker A, Van Hummelen P, Bakkus M, Vande Broek I, De Wever J, De Waele M et al. Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 2007; 92: 440-449. (Pubitemid 350144289)
15. Gondi CS, Veeravalli KK, Gorantla B, Dinh DH, Fassett D, Klopfenstein JD et al. Human umbilical cord blood stem cells show PDGF-D-dependent glioma cell tropism in vitro and in vivo. Neuro Oncol 2010; 12: 453-465.
16. Ozen O, Krebs B, Hemmerlein B, Pekrun A, Kretzschmar H, Herms J. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance. Clin Cancer Res 2004; 10: 4746-4753. (Pubitemid 38955526)
17. Chetty C, Bhoopathi P, Lakka SS, Rao JS. MMP-2 siRNA induced Fas/CD95-mediated extrinsic II apoptotic pathway in the A549 lung adenocarcinoma cell line. Oncogene 2007; 26: 7675-7683. (Pubitemid 350224224)
18. Bhoopathi P, Chetty C, Kunigal S, Vanamala SK, Rao JS, Lakka SS. Blockade of tumor growth due to matrix metalloproteinase-9 inhibition is mediated by sequential activation of beta1-integrin, ERK, and NF-kappaB. J Biol Chem 2008; 283: 1545-1552.
19. Kim SK, Kim SU, Park IH, Bang JH, Aboody KS, Wang KC et al. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res 2006; 12: 5550-5556. (Pubitemid 44497273)
20. Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005; 23: 879-894. (Pubitemid 41170944)
21. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA 2003; 100: 13513-13518. (Pubitemid 37444773)
22. Lazarini F, Tham TN, Casanova P, renzana-Seisdedos F, Dubois-Dalcq M. Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 2003; 42: 139-148. (Pubitemid 36565118)
23. Reiss K,Mentlein R, Sievers J, Hartmann D. Stromal cell-derived factor 1 is secreted by meningeal cells and acts as chemotactic factor on neuronal stem cells of the cerebellar external granular layer. Neuroscience 2002; 115: 295-305. (Pubitemid 35232708)
24. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 2004; 101: 18117-18122. (Pubitemid 40054083)
25. Dao MA, Creer MH, Nolta JA, Verfaillie CM. Biology of umbilical cord blood progenitors in bone marrow niches. Blood 2007; 110: 74-81. (Pubitemid 47026821)
26. Erlandsson A, Larsson J, Forsberg-Nilsson K. Stem cell factor is a chemoattractant and a survival factor for CNS stem cells. Exp Cell Res 2004; 301: 201-210. (Pubitemid 39504973)
27. Guo Y, Hangoc G, Bian H, Pelus LM, Broxmeyer HE. SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells. Stem Cells 2005; 23: 1324-1332. (Pubitemid 41504920)
28. Rosu-Myles M, Gallacher L, Murdoch B, Hess DA, Keeney M, Kelvin D et al. The human hematopoietic stem cell compartment is heterogeneous for CXCR4 expression. Proc Natl Acad Sci USA 2000; 97: 14626-14631. (Pubitemid 32016626)
29. Wynn RF, Hart CA, Corradi-Perini C, O'Neill L, Evans CA, Wraith JE et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004; 104: 2643-2645. (Pubitemid 39434942)
30. Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005; 106: 419-427. (Pubitemid 40981232)
31. Chetty C, Bhoopathi P, Joseph P, Chittivelu S, Rao JS, Lakka SS. Adenovirus-mediated siRNA against MMP-2 suppresses tumor growth and lung metastasis in mice. Mol Cancer Ther 2006; 5: 2289-2299. (Pubitemid 44530466)
32. Lee IO, Kim JH, Choi YJ, Pillinger MH, Kim SY, Blaser MJ et al. Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/ STAT signal transduction pathways in gastric epithelial cells. J Biol Chem 2010; 285: 16042-16050.
33. Bhoopathi P, Chetty C, Gujrati M, Dinh DH, Rao JS, Lakka SS. The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine. Br J Cancer 2010; 102: 530-540.
34. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159. (Pubitemid 17064313)
35. Workman P, Balmain A, Hickman JA, McNally NJ, Rohas AM, Mitchison NA et al. UKCCCR guidelines for the welfare of animals in experimental neoplasia. Lab Anim 1988; 22: 195-201.
36. Shu Q, Antalffy B, Su JM, Adesina A, Ou CN, Pietsch T et al. Valproic acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts. Clin Cancer Res 2006; 12: 4687-4694. (Pubitemid 44297822)